ArticleNature biomedical engineering2025

Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2.

Lester Frei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.